DNAVSSXTC• 6 Months (Normalized)
DNA vs SXTC (Ginkgo Bioworks Holdings Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Apr 1 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+54.05%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
SXTC Performance $2.51
+%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+54.05 pts
DNA outperforming by 54.05 percentage points
DNASXTC
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | DNA Price | DNA Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $10.46 | +54.05% | $- | - | |
| Sep 25, 2026 | $10.66 | +57.00% | $- | - | |
| Sep 24, 2026 | $10.25 | +50.96% | $- | - | |
| Sep 23, 2026 | $8.58 | +26.36% | $2.51 | -98.26% | +124.62% |
| Sep 22, 2026 | $9.37 | +38.00% | $- | - | |
| Sep 21, 2026 | $7.98 | +17.53% | $2.38 | -98.35% | +115.88% |
| Sep 18, 2026 | $7.88 | +16.05% | $2.40 | -98.33% | +114.38% |
| Sep 17, 2026 | $7.84 | +15.46% | $2.44 | -98.31% | +113.77% |
| Sep 16, 2026 | $7.06 | +3.98% | $2.19 | -98.48% | +102.46% |
| Sep 15, 2026 | $6.99 | +2.95% | $2.36 | -98.36% | +101.31% |
| Sep 14, 2026 | $7.01 | +3.24% | $2.66 | -98.15% | +101.39% |
| Sep 11, 2026 | $6.75 | -0.59% | $2.56 | -98.22% | +97.63% |
| Sep 10, 2026 | $6.78 | -0.15% | $1.93 | -98.66% | +98.51% |
| Sep 09, 2026 | $6.79 | +0.00% | $2.14 | -98.51% | +98.51% |
| Sep 08, 2026 | $6.94 | +2.21% | $2.24 | -98.44% | +100.65% |
Page 1 of 9